Solid lipid budesonide microparticles for controlled release inhalation therapy

AAPS Journal

Volumn 11, Issue 4, 2009, Pages 771-778

  Mezzena, Matteo ^a   Scalia, Santo ^a   Young, Paul M ^b   Traini, Daniela ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Controlled release; Dry powder inhalation; Solid lipid microparticles

Indexed keywords

BUDESONIDE; GLYCEROL BEHENATE;

AEROSOL; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DIFFUSION; DRUG SOLUBILITY; EMULSION; PARTICLE SIZE; POWDER; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; THERMODYNAMICS; X RAY POWDER DIFFRACTION;

ADMINISTRATION, INHALATION; AEROSOLS; ALGORITHMS; BRONCHODILATOR AGENTS; BUDESONIDE; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; DIFFUSION; EMULSIONS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; POWDERS; RESPIRATORY SYSTEM; SOLUBILITY; X-RAY DIFFRACTION;

EID: 72949090128     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-009-9148-6     Document Type: Article

References (34)

1. Traini D, Young PM. Delivery of antibiotics to the respiratory tract for pulmonary infection: an update. Expert Opinion on Drug Delivery, Sep 2009, Vol. 6, No. 9 doi: 10.1517/17425240903110710
2. G Scheuch MJ Kohlhaeufl P Brand R Siekmeier 2006 Clinical perspectives on pulmonary systemic and macromolecular delivery Adv Drug Deliv Rev 58 9-10 996 1008 10.1016/j.addr.2006.07.009 1:CAS:528:DC%2BD28Xht1Sht7jK 16996638 (Pubitemid 44709266)
3. JN Pritchard 2001 The influence of lung deposition on clinical response 1 J Aerosol Med 14 S19 S26 10.1089/08942680150506303 1:CAS:528: DC%2BD3MXhs1yktrc%3D 11424889
4. XM Zeng GP Martin C Marriott 1995 The controlled delivery of drugs to the lung Int J Pharm 124 2 149 164 10.1016/0378-5173(95)00104-Q 1:CAS:528:DyaK2MXnslygsr0%3D
5. R Salama D Traini HK Chan PM Young 2009 Recent advances in controlled release pulmonary therapy Curr Drug Discov 6 404 414 1:CAS:528: DC%2BD1MXhtFKksrzP
6. M Trotta F Debernardi O Caputo 2003 Preparation of solid lipid nanoparticles by a solvent emulsitication-diffusion technique Int J Pharm 257 1-2 153 160 10.1016/S0378-5173(03)00135-2 1:CAS:528:DC%2BD3sXjtVemsrY%3D 12711170 (Pubitemid 36507041)
7. IR Dos Santos J Richard B Pech C Thies JP Benoit 2002 Microencapsulation of protein particles within lipids using a novel supercritical fluid process Int J Pharm 242 1-2 69 78 10.1016/S0378-5173(02)00149-7 (Pubitemid 34899436)
8. S Jaspart G Piel L Delattre B Evrard 2005 Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications Expert Opin Drug Deliv 2 1 75 87 10.1517/17425247.2.1.75 1:CAS:528: DC%2BD2MXhtlKrtLs%3D 16296736 (Pubitemid 40123884)
9. LJ Zhang Y Qian CX Long Y Chen 2008 Systematic procedures for formulation design of drug-loaded solid lipid microparticles: selection of carrier material and stabilizer Ind Eng Chem Res 47 16 6091 6100 10.1021/ie7017806 1:CAS:528:DC%2BD1cXot1ahurw%3D
10. RH Muller K Mader S Gohla 2000 Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art Eur J Pharm Biopharm 50 1 161 177 10.1016/S0939-6411(00)00087-4 1:CAS:528:DC%2BD3cXjslyisrg%3D 10840199 (Pubitemid 30326695)
11. S Jaspart P Bertholet G Piel JM Dogne L Delattre B Evrard 2007 Solid lipid microparticles as a sustained release system for pulmonary drug delivery Eur J Pharm Biopharm 65 1 47 56 10.1016/j.ejpb.2006.07.006 1:CAS:528: DC%2BD28Xht1KlsL%2FO 16962749 (Pubitemid 44827691)
12. T Sebti K Amighi 2006 Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation Eur J Pharm Biopharm 63 1 51 58 10.1016/j.ejpb.2005.11.003 1:CAS:528:DC%2BD28XjtFGhurg%3D 16380243
13. RO Cook RK Pannu IW Kellaway 2005 Novel sustained release microspheres for pulmonary drug delivery J Control Release 104 1 79 90 10.1016/j.jconrel. 2005.01.003 1:CAS:528:DC%2BD2MXjvVClsLY%3D 15866336 (Pubitemid 40615237)
14. V Sanna N Kirschvink P Gustin E Gavini I Roland L Delattre, et al. 2004 Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration AAPS PharmSciTech 5 2 e27 10.1208/pt050227 15760085
15. Pople P, Singh KK. Glyceryl behanate-monograph. In: Rowe RC, Sheskey PJ, Quinn ME, editors. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical Press; 2009. p. 286-8.
16. A Dalpiaz M Mezzena A Scatturin S Scalia 2008 Solid lipid microparticles for the stability enhancement of the polar drug N-6-cyclopentyladenosine Int J Pharm 355 1-2 81 86 10.1016/j.ijpharm.2007.11.044 1:CAS:528:DC%2BD1cXkt1ygt7g%3D 18178347
17. Appendix XII B. Dissolution guidance on dissolution testing. British Pharmacopoeia Volume 2009. Norwich, UK: TSO; 2009.
18. RO Salama D Traini HK Chan PM Young 2008 Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols Eur J Pharm Biopharm 70 1 145 152 10.1016/j.ejpb.2008.04.009 1:CAS:528:DC%2BD1cXhtVOitrjM 18534832
19. OR Moss 1979 Simulants of lung interstitial fluid Health Phys 36 3 447 448 1:CAS:528:DyaE1MXltF2lsL0%3D 489300
20. NM Davies MR Feddah 2003 A novel method for assessing dissolution of aerosol inhaler products Int J Pharm 255 1-2 175 187 10.1016/S0378-5173(03) 00091-7 1:CAS:528:DC%2BD3sXisVGksL4%3D 12672613 (Pubitemid 36369601)
21. Section 2.9.18-appendix XII C. Consistency of formulated preparations for inhalation. British Pharmacopoeia, 2009.
22. R Tursilli G Piel L Delattre S Scalia 2007 Solid lipid microparticles containing the sunscreen agent, octyl-dimethylaminobenzoate: effect of the vehicle Eur J Pharm Biopharm 66 3 483 487 10.1016/j.ejpb.2007.02.017 1:CAS:528:DC%2BD2sXlsFKmur0%3D 17407809 (Pubitemid 46756230)
23. L Tajber DO Corrigan OI Corrigan AM Healy 2009 Spray drying of budesonide, formoterol fumarate and their composites-I. Physicochemical characterisation Int J Pharm 367 1-2 79 85 10.1016/j.ijpharm.2008.09.030 1:CAS:528:DC%2BD1MXpsF2mtA%3D%3D 18929631
24. SP Velaga R Berger J Carlfors 2002 Supercritical fluids crystallization of budesonide and flunisolide Pharm Res 19 10 1564 1571 10.1023/A:1020477204512 1:CAS:528:DC%2BD38XnsFSgtrk%3D 12425477 (Pubitemid 35266564)
25. JB Brubach V Jannin B Mahler C Bourgaux P Lessieur P Roy, et al. 2007 Structural and thermal characterization of glyceryl behenate by X-ray diffraction coupled to differential calorimetry and infrared spectroscopy Int J Pharm 336 2 248 256 10.1016/j.ijpharm.2006.11.057 1:CAS:528:DC%2BD2sXkvFWquro%3D 17207945 (Pubitemid 46670648)
26. EB Souto W Mehnert RH Muller 2006 Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC J Microencapsul 23 4 417 433 10.1080/02652040600612439 1:CAS:528:DC%2BD28XovVOqsbc%3D 16854817 (Pubitemid 44132550)
27. T Eldem P Speiser H Altorfer 1991 Polymorphic behavior of sprayed lipid micropellets and its evaluation by differential scanning calorimetry and scanning electron microscopy Pharm Res 8 2 178 184 10.1023/A:1015831801813 1:CAS:528:DyaK3MXhsFSjt70%3D 2023865
28. M Rao A Ranpise S Borate K Thanki 2009 Mechanistic evaluation of the effect of sintering on Compritol 888 ATO matrices AAPS PharmSciTech 10 2 355 360 10.1208/s12249-009-9211-8 19333763
29. S Pham TS Wiedmann 2001 Note: dissolution of aerosol particles of budesonide in Survanta, a model lung surfactant J Pharm Sci 90 1 98 104 10.1002/1520-6017(200101)90:1<98::AID-JPS11>3.0.CO;2-5 1:CAS:528:DC%2BD3MXkvVWlsg%3D%3D 11064383 (Pubitemid 32050481)
30. JW Moore HH Flanner 1996 Mathematical comparison of dissolution profiles Pharm Tech 20 64 75
31. Guidence for industry; Dissolution testing of immediate release solid dosage forms. In: Administration FaD, editor. August 1997.
32. J Zhang S Ebbens X Chen Z Jin S Luk C Madden, et al. 2006 Determination of the surface free energy of crystalline and amorphous lactose by atomic force microscopy adhesion measurement Pharm Res 23 2 401 407 10.1007/s11095-005-9144-1 16421667 (Pubitemid 43237870)
33. HE Newell G Buckton DA Butler F Thielmann DR Williams 2001 The use of inverse phase gas chromatography to measure the surface energy of crystalline, amorphous, and recently milled lactose Pharmaceut Res 18 5 662 666 10.1023/A:1011089511959 1:CAS:528:DC%2BD3MXltVKmtLY%3D (Pubitemid 32595796)
34. IJ Smith M Parry-Billings 2003 The inhalers of the future? A review of dry powder devices on the market today Pulm Pharmacol Ther 16 2 79 95 10.1016/S1094-5539(02)00147-5 1:CAS:528:DC%2BD3sXisFWlsbg%3D 12670777 (Pubitemid 36372063)